Cargando…

Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence

The relationship between lead exposure and neurological disorders has been extensively studied, but the effects of lead exposure on hepatotoxicity are unknown. Metabolically related fatty liver disease (MAFLD) is an update of previous non-alcoholic fatty liver disease (NAFLD). It redefines the diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chenyu, Li, Yuanyuan, Ding, Ran, Xing, Huiwu, Wang, Ruijue, Zhang, Mingman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597460/
https://www.ncbi.nlm.nih.gov/pubmed/36311639
http://dx.doi.org/10.3389/fpubh.2022.1000403
_version_ 1784816096393560064
author Yang, Chenyu
Li, Yuanyuan
Ding, Ran
Xing, Huiwu
Wang, Ruijue
Zhang, Mingman
author_facet Yang, Chenyu
Li, Yuanyuan
Ding, Ran
Xing, Huiwu
Wang, Ruijue
Zhang, Mingman
author_sort Yang, Chenyu
collection PubMed
description The relationship between lead exposure and neurological disorders has been extensively studied, but the effects of lead exposure on hepatotoxicity are unknown. Metabolically related fatty liver disease (MAFLD) is an update of previous non-alcoholic fatty liver disease (NAFLD). It redefines the diagnostic conditions and emphasizes metabolic factors while considering non-alcoholic factors. Lead can affect the endocrine system and metabolism, so we believe that lead exposure may contribute to MAFLD. 41,723 individuals who had undergone blood lead testing from 2005 to 2018 in the National Health and Nutrition Examination Survey (NHANES) database were selected for this study. The characteristics of population lead exposure in the last decade or so, the effect of lead exposure on liver function and whether lead exposure can cause MAFLD were analyzed. Co-variates were adjusted according to age, ethnicity, body mass index (BMI), waist circumference, visceral adiposity index (VAI), poverty indices (PIR), diabetes, hypertension, and hyperlipidemia. The results showed that blood lead concentrations stabilized at a low level after a decreasing trend from year to year. The differences in blood lead concentrations were associated with differences in age, sex, race, education level, and PIR. Lead exposure was an independent risk factor for MAFLD, and lead and nine other factors were used as independent risk factors for MAFLD, so a nomogram was established to predict the prevalence probability of MAFLD.
format Online
Article
Text
id pubmed-9597460
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95974602022-10-27 Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence Yang, Chenyu Li, Yuanyuan Ding, Ran Xing, Huiwu Wang, Ruijue Zhang, Mingman Front Public Health Public Health The relationship between lead exposure and neurological disorders has been extensively studied, but the effects of lead exposure on hepatotoxicity are unknown. Metabolically related fatty liver disease (MAFLD) is an update of previous non-alcoholic fatty liver disease (NAFLD). It redefines the diagnostic conditions and emphasizes metabolic factors while considering non-alcoholic factors. Lead can affect the endocrine system and metabolism, so we believe that lead exposure may contribute to MAFLD. 41,723 individuals who had undergone blood lead testing from 2005 to 2018 in the National Health and Nutrition Examination Survey (NHANES) database were selected for this study. The characteristics of population lead exposure in the last decade or so, the effect of lead exposure on liver function and whether lead exposure can cause MAFLD were analyzed. Co-variates were adjusted according to age, ethnicity, body mass index (BMI), waist circumference, visceral adiposity index (VAI), poverty indices (PIR), diabetes, hypertension, and hyperlipidemia. The results showed that blood lead concentrations stabilized at a low level after a decreasing trend from year to year. The differences in blood lead concentrations were associated with differences in age, sex, race, education level, and PIR. Lead exposure was an independent risk factor for MAFLD, and lead and nine other factors were used as independent risk factors for MAFLD, so a nomogram was established to predict the prevalence probability of MAFLD. Frontiers Media S.A. 2022-10-12 /pmc/articles/PMC9597460/ /pubmed/36311639 http://dx.doi.org/10.3389/fpubh.2022.1000403 Text en Copyright © 2022 Yang, Li, Ding, Xing, Wang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Yang, Chenyu
Li, Yuanyuan
Ding, Ran
Xing, Huiwu
Wang, Ruijue
Zhang, Mingman
Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
title Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
title_full Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
title_fullStr Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
title_full_unstemmed Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
title_short Lead exposure as a causative factor for metabolic associated fatty liver disease (MAFLD) and a lead exposure related nomogram for MAFLD prevalence
title_sort lead exposure as a causative factor for metabolic associated fatty liver disease (mafld) and a lead exposure related nomogram for mafld prevalence
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597460/
https://www.ncbi.nlm.nih.gov/pubmed/36311639
http://dx.doi.org/10.3389/fpubh.2022.1000403
work_keys_str_mv AT yangchenyu leadexposureasacausativefactorformetabolicassociatedfattyliverdiseasemafldandaleadexposurerelatednomogramformafldprevalence
AT liyuanyuan leadexposureasacausativefactorformetabolicassociatedfattyliverdiseasemafldandaleadexposurerelatednomogramformafldprevalence
AT dingran leadexposureasacausativefactorformetabolicassociatedfattyliverdiseasemafldandaleadexposurerelatednomogramformafldprevalence
AT xinghuiwu leadexposureasacausativefactorformetabolicassociatedfattyliverdiseasemafldandaleadexposurerelatednomogramformafldprevalence
AT wangruijue leadexposureasacausativefactorformetabolicassociatedfattyliverdiseasemafldandaleadexposurerelatednomogramformafldprevalence
AT zhangmingman leadexposureasacausativefactorformetabolicassociatedfattyliverdiseasemafldandaleadexposurerelatednomogramformafldprevalence